Type / Class
Equity / Ordinary Shares, par value $0.000006 per share
Shares outstanding
1,091,129,524
Number of holders
35
Total 13F shares, excl. options
10,842,196
Shares change
+487,680
Total reported value, excl. options
$231,479,000
Value change
+$10,475,120
Number of buys
21
Number of sells
-11
Price
$21.35

Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q1 2018

41 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q1 2018.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10,842,196 shares of 1,091,129,524 outstanding shares and own 0.99% of the company stock.
Largest 10 shareholders include FMR LLC (4,866,682 shares), GILDER GAGNON HOWE & CO LLC (903,855 shares), Myriad Asset Management Ltd. (890,900 shares), PRICE T ROWE ASSOCIATES INC /MD/ (794,492 shares), ORBIMED ADVISORS LLC (658,160 shares), Segantii Capital Management Ltd (385,000 shares), Cormorant Asset Management, LP (333,166 shares), Rock Springs Capital Management LP (295,000 shares), Vivo Capital, LLC (283,787 shares), and Marshall Wace North America L.P. (208,269 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.